Decades of MCL Treatment Advancements a ‘Godsend’ for Patients

February 14, 2022

Dr. Jeffrey Schriber, director of hematologic malignancies at Cancer Treatment Centers of America® (CTCA) Phoenix, shared his expertise during an interview with CURE on how the treatment landscape of mantle cell lymphoma has drastically changed for the better in recent decades.

Read more here

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.